|
Marcone to Be Featured on Now We Know! with Steve Guttenberg – Airing March 28 on CNBC Denver, CO – The upcoming episode of Now We Know! with Steve Guttenberg, airing March 28 at 11a ET on CNBC will feature Marcone, a company focused on streamlining supply chain operations through advanced software solutions. The segment provides an inside … Continue reading
|
“This review was conducted independently and was not sponsored or paid for by any vendor mentioned.” — Kerrie Watson, Senior Auditor at Gartner Six-week accuracy study by Gartner senior auditor reveals significant data quality gaps between Leadpipe, RB2B, Warmly, Clearbit, … Continue reading
|
|
The Prime Cleaner has earned the top ranking for house cleaning services in Pinecrest, serving the prestigious South Miami-Dade neighborhood’s discerning homeowners. Pinecrest homeowners rank The Prime Cleaner as the top house cleaning service in the area, citing reliability, thoroughness, … Continue reading
|
DelveInsight’s, “PI3K Inhibitor Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in PI3K Inhibitor pipeline landscape. It covers the PI3K Inhibitor pipeline drug profiles, including PI3K Inhibitor clinical and nonclinical stage products. It also … Continue reading
|
|
DelveInsight’s “ALK Inhibitors Pipeline Insight 2026” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the ALK Inhibitors pipeline landscape. It covers the ALK Inhibitors Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading
|
DelveInsight’s, “Spleen Tyrosine Kinase (SYK) Inhibitors Pipeline Insight, 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Spleen Tyrosine Kinase (SYK) Inhibitors pipeline landscape. It covers the SYK Inhibitor pipeline drug profiles, including clinical and nonclinical … Continue reading
|
|
DelveInsight’s “PARP inhibitor Pipeline Insights 2026” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the PARP inhibitor pipeline landscape. It covers the PARP inhibitor pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading
|
DelveInsight’s “NLRP3 Protein Inhibitors Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the NLRP3 Protein Inhibitors pipeline landscape. It covers the NLRP3 Protein Inhibitors Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading
|
|
Fibrodysplasia Ossificans Progressiva Market The Fibrodysplasia Ossificans Progressiva (FOP) market is projected to witness substantial growth during the forecast period, primarily driven by increasing disease awareness and improving diagnosis rates. In addition, the introduction of multiple pipeline therapies across various … Continue reading
|
Lupus Nephritis Market Prominent Lupus Nephritis companies working in the market are Aurinia Pharmaceuticals, Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Otsuka Pharmaceutical, MorphoSys, Vertice Pharma, Pharmaceutical Associates Inc., Sun Pharmaceutical, Abbott, Johnson & Johnson Private Limited, Bayer, Sanofi, Sumitomo Corporation, … Continue reading
|
